{"id":508,"date":"2022-05-04T12:00:00","date_gmt":"2022-05-04T12:00:00","guid":{"rendered":"https:\/\/cpmiclinical.com\/?p=508"},"modified":"2022-05-05T13:27:25","modified_gmt":"2022-05-05T13:27:25","slug":"nash-the-elephant-in-the-room","status":"publish","type":"post","link":"https:\/\/cpmiclinical.com\/es\/nash-the-elephant-in-the-room\/","title":{"rendered":"NASH: El elefante en la habitaci\u00f3n"},"content":{"rendered":"<p>Cuando viene a la mente la enfermedad hep\u00e1tica, muchos est\u00e1n m\u00e1s familiarizados con los tipos que ocurren en los grandes bebedores de alcohol o por la hepatitis C. Por el contrario, la enfermedad hep\u00e1tica cr\u00f3nica m\u00e1s com\u00fan en las poblaciones occidentales es la enfermedad del h\u00edgado graso no alcoh\u00f3lico (NAFLD, por sus siglas en ingl\u00e9s). NAFLD afecta a las personas que beben poco o nada de alcohol, pero enfrentan el mismo da\u00f1o hep\u00e1tico progresivo que aquellos que abusan cr\u00f3nicamente de \u00e9l. Aproximadamente 20% de personas con NAFLD progresar\u00e1n a esteatohepatitis no alcoh\u00f3lica (NASH), una forma m\u00e1s peligrosa de enfermedad del h\u00edgado graso. Con NAFLD en aumento, tambi\u00e9n lo est\u00e1 NASH, y es el elefante en la habitaci\u00f3n.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Inflamaci\u00f3n cr\u00f3nica y EHNA<\/strong><gwmw style=\"display:none;\"><gwmw style=\"display:none;\"><\/h2>\n\n\n\n<p><a href=\"https:\/\/liverfoundation.org\/for-patients\/about-the-liver\/diseases-of-the-liver\/nonalcoholic-steatohepatitis-information-center\/nash-definition-prevalence\/#:~:text=NAFLD%20is%20the%20most%20common,of%20adults%20in%20the%20U.S.).\">Enfermedad del h\u00edgado graso<\/a> es cuando comienza a acumularse demasiada grasa en el h\u00edgado. Algunas personas tienen un h\u00edgado graso simple y no tendr\u00e1n ning\u00fan problema, mientras que aproximadamente una cuarta parte avanzar\u00e1 a la etapa NASH. Por razones que a\u00fan estamos tratando de comprender, la acumulaci\u00f3n excesiva de grasa desencadena la respuesta de curaci\u00f3n del cuerpo. Aunque se supone que esto es algo bueno, la curaci\u00f3n se presenta en forma de inflamaci\u00f3n cr\u00f3nica. Con el tiempo, esta funci\u00f3n corporal bien intencionada comienza a cicatrizar y da\u00f1ar el h\u00edgado, lo que eventualmente afecta su funci\u00f3n.<\/p>\n\n\n\n<p>Si no se trata, NASH puede progresar a cirrosis, c\u00e1ncer de h\u00edgado e insuficiencia hep\u00e1tica.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Prevalencia de EHNA<\/strong><gwmw style=\"display:none;\"><gwmw style=\"display:none;\"><\/h2>\n\n\n\n<p>Las estimaciones actuales muestran que aproximadamente 12% de estadounidenses tienen NASH. Los datos tambi\u00e9n muestran que las personas que progresan de NAFLD a NASH son <a href=\"https:\/\/www.the-nash-education-program.com\/what-is-nash\/how-prevalent-is-nash\/\">proyectado para subir 63% para 2030<\/a>. en el 2019 <a href=\"https:\/\/www.ajmc.com\/view\/nash-has-gone-under-the-radar-but-it-is-the-elephant-in-the-room-panelists-say\">Conferencia AMCP Nexus<\/a>, los m\u00e9dicos se refirieron a NASH como el &quot;elefante en la habitaci\u00f3n&quot; debido a varios factores:<gwmw style=\"display:none;\"><gwmw style=\"display:none;\"><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>A pesar de la prevalencia, actualmente no existen tratamientos aprobados por la FDA para ello.<\/li><li>Los sistemas de salud contin\u00faan luchando para identificar qu\u00e9 pacientes est\u00e1n en riesgo, as\u00ed como las personas que ya tienen cicatrices hep\u00e1ticas avanzadas. Esto se debe principalmente a:<ul><li>No tener forma de saber qu\u00e9 pacientes con NAFLD progresar\u00e1n a NASH.<\/li><\/ul><ul><li>Diversas experiencias en la progresi\u00f3n de la enfermedad para aquellos que desarrollan NASH. Por ejemplo, algunas personas tardan muchos a\u00f1os, incluso d\u00e9cadas, en progresar a la cirrosis, mientras que otras son m\u00e1s r\u00e1pidas.<\/li><\/ul><\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Dieta poco saludable + Inactividad = EHNA<\/strong><gwmw style=\"display:none;\"><gwmw style=\"display:none;\"><\/h2>\n\n\n\n<p>El lado positivo para el futuro de NASH es que la mayor\u00eda de los principales factores de riesgo de esta afecci\u00f3n se pueden prevenir. En nuestra cultura occidental, amamos nuestra comida poco saludable y las actividades sedentarias que dejan nuestro cuerpo con m\u00e1s grasa de la que puede usar, por lo que el exceso se almacena en el h\u00edgado. A medida que la cintura sigue creciendo, tambi\u00e9n lo hace nuestro riesgo de EHNA.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-medium is-resized\"><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/Unhealthy-food-1-300x180.jpg\" alt=\"Unhealthy food\" class=\"wp-image-512\" width=\"426\" height=\"256\" srcset=\"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/Unhealthy-food-1-300x180.jpg 300w, https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/Unhealthy-food-1-18x12.jpg 18w, https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/Unhealthy-food-1.jpg 600w\" sizes=\"(max-width: 426px) 100vw, 426px\" \/><figcaption><gwmw style=\"display:none;\"><\/figcaption><\/figure><\/div>\n\n\n\n<p>Pueden pasar a\u00f1os hasta que se desarrolle NASH, y la mayor\u00eda de las personas no saben que la tienen porque los s\u00edntomas generalmente no est\u00e1n presentes hasta las etapas posteriores. Al estar consciente de los factores de riesgo de la EHNA, puede comenzar a tomar decisiones m\u00e1s saludables y comenzar un control hep\u00e1tico regular con su proveedor.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-medium is-resized\"><img decoding=\"async\" src=\"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/CPMI_Facebook_NASH-InsulinResistance_27APR2022_AR-1-300x158.png\" alt=\"Insulin resistance can increase your risk for NASH\" class=\"wp-image-511\" width=\"403\" height=\"212\" srcset=\"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/CPMI_Facebook_NASH-InsulinResistance_27APR2022_AR-1-300x158.png 300w, https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/CPMI_Facebook_NASH-InsulinResistance_27APR2022_AR-1-18x9.png 18w, https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/CPMI_Facebook_NASH-InsulinResistance_27APR2022_AR-1.png 600w\" sizes=\"(max-width: 403px) 100vw, 403px\" \/><figcaption><gwmw style=\"display:none;\"><\/figcaption><\/figure><\/div>\n\n\n\n<p>Los factores de riesgo de NASH incluyen:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Obesidad<\/strong><\/li><li><strong>Hipertensi\u00f3n<\/strong><\/li><li><strong>Colesterol alto<\/strong><\/li><li><strong>Diabetes tipo 2<\/strong><\/li><li><strong>Dieta no saludable<\/strong><\/li><\/ul>\n\n\n\n<p>La esperanza est\u00e1 en el horizonte con la investigaci\u00f3n en curso en todo el mundo sobre los tratamientos de NASH. Clinical Pharmacology of Miami tiene varios estudios de investigaci\u00f3n actuales y futuros sobre la salud del h\u00edgado y posibles tratamientos. Haga clic en los enlaces a continuaci\u00f3n para obtener m\u00e1s informaci\u00f3n o cont\u00e1ctenos al (305) 817-2900.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-medium is-resized\"><img decoding=\"async\" src=\"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/ALH_Facebook_Know-Your-Liver_26APR2022_AW-1-300x158.png\" alt=\"Get to know your liver\" class=\"wp-image-510\" width=\"443\" height=\"233\" srcset=\"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/ALH_Facebook_Know-Your-Liver_26APR2022_AW-1-300x158.png 300w, https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/ALH_Facebook_Know-Your-Liver_26APR2022_AW-1-18x9.png 18w, https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/ALH_Facebook_Know-Your-Liver_26APR2022_AW-1.png 600w\" sizes=\"(max-width: 443px) 100vw, 443px\" \/><figcaption><gwmw style=\"display:none;\"><\/figcaption><\/figure><\/div>\n\n\n\n<ul class=\"wp-block-list\"><li><a href=\"https:\/\/cpmiclinical.com\/es\/studies\/#!\/study\/3\">Fibroscan GRATIS para adultos con riesgo de enfermedad hep\u00e1tica<\/a><\/li><li><a href=\"https:\/\/cpmiclinical.com\/es\/studies\/#!\/study\/54\">Mujeres con insuficiencia hep\u00e1tica<\/a><\/li><li><a href=\"https:\/\/cpmiclinical.com\/es\/studies\/#!\/study\/50\">Adultos con enfermedad hep\u00e1tica<\/a><\/li><li><a href=\"https:\/\/cpmiclinical.com\/es\/studies\/#!\/study\/83\">Adultos con EHNA<\/a><\/li><\/ul>\n\n\n\n<p>Fuentes:<\/p>\n\n\n\n<p><a href=\"https:\/\/www.pfizer.com\/news\/featured_stories\/featured_stories_detail\/the_growing_epidemic_of_non_alcoholic_steatohepatitis_nash_fatty_liver_disease\">https:\/\/www.pfizer.com\/news\/featured_stories\/featured_stories_detail\/the_growing_epidemic_of_non_alcoholic_steatohepatitis_nash_fatty_liver_disease<\/a><a href=\"https:\/\/www.healthwellfoundation.org\/wp-content\/uploads\/2020\/10\/NASH.pdf\">https:\/\/www.healthwellfoundation.org\/wp-content\/uploads\/2020\/10\/NASH.pdf<\/a><gwmw style=\"display:none;\"><\/p>","protected":false},"excerpt":{"rendered":"<p>Cuando viene a la mente la enfermedad hep\u00e1tica, muchos est\u00e1n m\u00e1s familiarizados con los tipos que ocurren en los grandes bebedores de alcohol o por la hepatitis C. Por el contrario, la enfermedad hep\u00e1tica cr\u00f3nica m\u00e1s com\u00fan en las poblaciones occidentales es la enfermedad del h\u00edgado graso no alcoh\u00f3lico (NAFLD, por sus siglas en ingl\u00e9s). NAFLD afecta a las personas que beben poco o nada de alcohol pero enfrentan lo mismo... <\/p>\n<p class=\"read-more-container\"><a title=\"NASH: El elefante en la habitaci\u00f3n\" class=\"read-more button\" href=\"https:\/\/cpmiclinical.com\/es\/nash-the-elephant-in-the-room\/#more-508\" aria-label=\"Leer m\u00e1s sobre NASH: El elefante en la habitaci\u00f3n\">Lee mas<\/a><\/p>","protected":false},"author":1,"featured_media":513,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9,70],"tags":[57,60,54,64,55,61],"class_list":["post-508","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-research","category-nash","tag-blog","tag-clinical-trials","tag-fibroscan","tag-liver-health","tag-nafld","tag-research-volunteers","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NASH: The Elephant in the Room - Clinical Pharmacology of Miami<\/title>\n<meta name=\"description\" content=\"About 20% of people with NAFLD will progress to NASH. With NAFLD on the rise, so is NASH, and it\u2019s the elephant in the room.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cpmiclinical.com\/es\/nash-the-elephant-in-the-room\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NASH: The Elephant in the Room - Clinical Pharmacology of Miami\" \/>\n<meta property=\"og:description\" content=\"About 20% of people with NAFLD will progress to NASH. With NAFLD on the rise, so is NASH, and it\u2019s the elephant in the room.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cpmiclinical.com\/es\/nash-the-elephant-in-the-room\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Pharmacology of Miami\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-04T12:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-05T13:27:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/CPMI_Facebook_Blog-Elephant-in-the-Room_22APR2022_AW-1-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cpmi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"cpmi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/nash-the-elephant-in-the-room\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/nash-the-elephant-in-the-room\\\/\"},\"author\":{\"name\":\"cpmi\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#\\\/schema\\\/person\\\/8bce1b58752d60d24ab5df35fd3c3364\"},\"headline\":\"NASH: The Elephant in the Room\",\"datePublished\":\"2022-05-04T12:00:00+00:00\",\"dateModified\":\"2022-05-05T13:27:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/nash-the-elephant-in-the-room\\\/\"},\"wordCount\":560,\"publisher\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/nash-the-elephant-in-the-room\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/CPMI_Facebook_Blog-Elephant-in-the-Room_22APR2022_AW-1-1.jpg\",\"keywords\":[\"Blog\",\"Clinical trials\",\"Fibroscan\",\"liver health\",\"NAFLD\",\"Research volunteers\"],\"articleSection\":[\"Clinical Research\",\"NASH\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/nash-the-elephant-in-the-room\\\/\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/nash-the-elephant-in-the-room\\\/\",\"name\":\"NASH: The Elephant in the Room - Clinical Pharmacology of Miami\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/nash-the-elephant-in-the-room\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/nash-the-elephant-in-the-room\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/CPMI_Facebook_Blog-Elephant-in-the-Room_22APR2022_AW-1-1.jpg\",\"datePublished\":\"2022-05-04T12:00:00+00:00\",\"dateModified\":\"2022-05-05T13:27:25+00:00\",\"description\":\"About 20% of people with NAFLD will progress to NASH. With NAFLD on the rise, so is NASH, and it\u2019s the elephant in the room.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/nash-the-elephant-in-the-room\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cpmiclinical.com\\\/nash-the-elephant-in-the-room\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/nash-the-elephant-in-the-room\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/CPMI_Facebook_Blog-Elephant-in-the-Room_22APR2022_AW-1-1.jpg\",\"contentUrl\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/CPMI_Facebook_Blog-Elephant-in-the-Room_22APR2022_AW-1-1.jpg\",\"width\":1200,\"height\":630,\"caption\":\"NASH: The elephant in the room\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/nash-the-elephant-in-the-room\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cpmiclinical.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NASH: The Elephant in the Room\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#website\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/\",\"name\":\"Clinical Pharmacology of Miami\",\"description\":\"Clinical research in Miami \\\/ Hialeah, FL\",\"publisher\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cpmiclinical.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#organization\",\"name\":\"Clinical Pharmacology of Miami\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/CPMI-Blue-Logo-copy.webp\",\"contentUrl\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/CPMI-Blue-Logo-copy.webp\",\"width\":150,\"height\":134,\"caption\":\"Clinical Pharmacology of Miami\"},\"image\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#\\\/schema\\\/person\\\/8bce1b58752d60d24ab5df35fd3c3364\",\"name\":\"cpmi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c1143e0c8d8aaf6e97b68245ed35f7cd8cc1fd7a2aeb28dccb6c27b981d5923a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c1143e0c8d8aaf6e97b68245ed35f7cd8cc1fd7a2aeb28dccb6c27b981d5923a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c1143e0c8d8aaf6e97b68245ed35f7cd8cc1fd7a2aeb28dccb6c27b981d5923a?s=96&d=mm&r=g\",\"caption\":\"cpmi\"},\"sameAs\":[\"http:\\\/\\\/cpmi.wpengine.com\"],\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/es\\\/author\\\/cpmi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EHNA: El elefante en la habitaci\u00f3n - Farmacolog\u00eda Cl\u00ednica de Miami","description":"Aproximadamente el 20% de las personas con EHGNA progresar\u00e1n a EHNA. Con el aumento de la EHGNA, tambi\u00e9n aumenta la EHNA, y es un tema candente.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cpmiclinical.com\/es\/nash-the-elephant-in-the-room\/","og_locale":"es_MX","og_type":"article","og_title":"NASH: The Elephant in the Room - Clinical Pharmacology of Miami","og_description":"About 20% of people with NAFLD will progress to NASH. With NAFLD on the rise, so is NASH, and it\u2019s the elephant in the room.","og_url":"https:\/\/cpmiclinical.com\/es\/nash-the-elephant-in-the-room\/","og_site_name":"Clinical Pharmacology of Miami","article_published_time":"2022-05-04T12:00:00+00:00","article_modified_time":"2022-05-05T13:27:25+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/CPMI_Facebook_Blog-Elephant-in-the-Room_22APR2022_AW-1-1.jpg","type":"image\/jpeg"}],"author":"cpmi","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"cpmi","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cpmiclinical.com\/nash-the-elephant-in-the-room\/#article","isPartOf":{"@id":"https:\/\/cpmiclinical.com\/nash-the-elephant-in-the-room\/"},"author":{"name":"cpmi","@id":"https:\/\/cpmiclinical.com\/#\/schema\/person\/8bce1b58752d60d24ab5df35fd3c3364"},"headline":"NASH: The Elephant in the Room","datePublished":"2022-05-04T12:00:00+00:00","dateModified":"2022-05-05T13:27:25+00:00","mainEntityOfPage":{"@id":"https:\/\/cpmiclinical.com\/nash-the-elephant-in-the-room\/"},"wordCount":560,"publisher":{"@id":"https:\/\/cpmiclinical.com\/#organization"},"image":{"@id":"https:\/\/cpmiclinical.com\/nash-the-elephant-in-the-room\/#primaryimage"},"thumbnailUrl":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/CPMI_Facebook_Blog-Elephant-in-the-Room_22APR2022_AW-1-1.jpg","keywords":["Blog","Clinical trials","Fibroscan","liver health","NAFLD","Research volunteers"],"articleSection":["Clinical Research","NASH"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/cpmiclinical.com\/nash-the-elephant-in-the-room\/","url":"https:\/\/cpmiclinical.com\/nash-the-elephant-in-the-room\/","name":"EHNA: El elefante en la habitaci\u00f3n - Farmacolog\u00eda Cl\u00ednica de Miami","isPartOf":{"@id":"https:\/\/cpmiclinical.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cpmiclinical.com\/nash-the-elephant-in-the-room\/#primaryimage"},"image":{"@id":"https:\/\/cpmiclinical.com\/nash-the-elephant-in-the-room\/#primaryimage"},"thumbnailUrl":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/CPMI_Facebook_Blog-Elephant-in-the-Room_22APR2022_AW-1-1.jpg","datePublished":"2022-05-04T12:00:00+00:00","dateModified":"2022-05-05T13:27:25+00:00","description":"Aproximadamente el 20% de las personas con EHGNA progresar\u00e1n a EHNA. Con el aumento de la EHGNA, tambi\u00e9n aumenta la EHNA, y es un tema candente.","breadcrumb":{"@id":"https:\/\/cpmiclinical.com\/nash-the-elephant-in-the-room\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cpmiclinical.com\/nash-the-elephant-in-the-room\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/cpmiclinical.com\/nash-the-elephant-in-the-room\/#primaryimage","url":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/CPMI_Facebook_Blog-Elephant-in-the-Room_22APR2022_AW-1-1.jpg","contentUrl":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2022\/05\/CPMI_Facebook_Blog-Elephant-in-the-Room_22APR2022_AW-1-1.jpg","width":1200,"height":630,"caption":"NASH: The elephant in the room"},{"@type":"BreadcrumbList","@id":"https:\/\/cpmiclinical.com\/nash-the-elephant-in-the-room\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cpmiclinical.com\/"},{"@type":"ListItem","position":2,"name":"NASH: The Elephant in the Room"}]},{"@type":"WebSite","@id":"https:\/\/cpmiclinical.com\/#website","url":"https:\/\/cpmiclinical.com\/","name":"Clinical Pharmacology of Miami","description":"Investigaci\u00f3n cl\u00ednica en Miami \/ Hialeah, FL","publisher":{"@id":"https:\/\/cpmiclinical.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cpmiclinical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/cpmiclinical.com\/#organization","name":"Clinical Pharmacology of Miami","url":"https:\/\/cpmiclinical.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/cpmiclinical.com\/#\/schema\/logo\/image\/","url":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2026\/02\/CPMI-Blue-Logo-copy.webp","contentUrl":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2026\/02\/CPMI-Blue-Logo-copy.webp","width":150,"height":134,"caption":"Clinical Pharmacology of Miami"},"image":{"@id":"https:\/\/cpmiclinical.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cpmiclinical.com\/#\/schema\/person\/8bce1b58752d60d24ab5df35fd3c3364","name":"cpmi","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/c1143e0c8d8aaf6e97b68245ed35f7cd8cc1fd7a2aeb28dccb6c27b981d5923a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c1143e0c8d8aaf6e97b68245ed35f7cd8cc1fd7a2aeb28dccb6c27b981d5923a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c1143e0c8d8aaf6e97b68245ed35f7cd8cc1fd7a2aeb28dccb6c27b981d5923a?s=96&d=mm&r=g","caption":"cpmi"},"sameAs":["http:\/\/cpmi.wpengine.com"],"url":"https:\/\/cpmiclinical.com\/es\/author\/cpmi\/"}]}},"_links":{"self":[{"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/posts\/508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/comments?post=508"}],"version-history":[{"count":0,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/posts\/508\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/media\/513"}],"wp:attachment":[{"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/media?parent=508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/categories?post=508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/tags?post=508"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}